Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,316 | -8,431 | -4,884 | -17,211 | -11,808 |
| Depreciation Amortization | 494 | 323 | 162 | 488 | 330 |
| Accounts receivable | 409 | 527 | 612 | -1,848 | -1,518 |
| Other Working Capital | -1,001 | -115 | -413 | -938 | -1,451 |
| Other Operating Activity | 2,781 | 270 | 285 | 8,670 | 6,314 |
| Operating Cash Flow | $-12,635 | $-7,426 | $-4,238 | $-10,840 | $-8,133 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -557 | -431 | -293 | -672 | -496 |
| Purchase Sale Intangibles | -560 | -371 | -182 | -848 | -701 |
| Other Investing Activity | -560 | -371 | -182 | -848 | -701 |
| Investing Cash Flow | $-1,117 | $-802 | $-474 | $-1,520 | $-1,197 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 0 | N/A | 667 | 667 |
| Debt Repayment | 0 | 0 | N/A | -667 | -667 |
| Common Stock Issued | 2,497 | 2,185 | 2,005 | 3,487 | 3,221 |
| Other Financing Activity | -92 | 0 | 0 | 13,979 | 13,769 |
| Financing Cash Flow | $7,405 | $2,185 | $2,005 | $17,466 | $16,990 |
| Exchange Rate Effect | -44 | 16 | -14 | -59 | -72 |
| Beginning Cash Position | 22,369 | 22,369 | 22,369 | 17,322 | 17,322 |
| End Cash Position | 15,978 | 16,342 | 19,647 | 22,369 | 24,911 |
| Net Cash Flow | $-6,391 | $-6,027 | $-2,722 | $5,047 | $7,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,635 | -7,426 | -4,238 | -10,840 | -8,133 |
| Capital Expenditure | -557 | -431 | -293 | -672 | -496 |
| Free Cash Flow | -13,192 | -7,857 | -4,530 | -11,512 | -8,628 |